If you run a TRT or hormone clinic and you've tried advertising on Facebook or Google, you already know the pattern. The ad gets submitted. It sits in review a little too long. Then the rejection arrives — 'personal attributes,' 'prescription pharmaceuticals,' 'unacceptable business practices' — and no amount of appealing seems to produce a human who can explain what exactly crossed the line.
Push your luck twice more and the stakes change: it's not the ad that gets rejected, it's your ad account that gets disabled. For a clinic whose growth depends on paid acquisition, that's not an inconvenience. That's the engine seizing.
Here's the uncomfortable truth: the platforms are not going to change, and most agencies don't understand the rules well enough to work within them. But the rules can be worked within — and the clinics growing fastest right now are doing it with a two-layer strategy: compliant ads on top, platform-independent channels underneath.
Why the platforms restrict hormone therapy advertising
Meta prohibits ads that promote prescription drugs without authorization, and its 'personal attributes' policy bans creative that implies things about the viewer's medical condition — which is exactly what 'Low testosterone? We can help' does. Google restricts pharmaceutical categories and requires certification for many healthcare advertisers, with testosterone products sitting in the most restricted tier.
None of this is aimed at your clinic specifically. The policies exist because of supplement scams and telehealth pill mills. But the enforcement is automated, unforgiving, and indifferent to the fact that you're a legitimate physician-supervised practice. The algorithm can't tell the difference — so it errs on the side of rejection.
What gets TRT ads rejected (the specific triggers)
- Naming the medication or hormone: "testosterone," "TRT," and drug brand names trigger pharmaceutical review.
- Implying the viewer has a condition: "Suffering from low T?" violates personal-attributes policies.
- Promising prescriptions or outcomes: "Get your testosterone prescription today" is an automatic rejection.
- Before/after claims and specific physiological results, which fall under misleading-claims enforcement.
- Landing pages that do any of the above — the platforms crawl your destination, not just your ad.
What passes review — and still converts
Compliant TRT advertising works by moving the conversation up a level: from the treatment to the symptoms and outcomes men actually search for. Fatigue. Poor sleep. Losing strength in the gym despite training. Brain fog at work. Low drive. These are the felt experiences that bring a man to a TRT clinic — and they are all policy-safe territory.
The creative talks about energy, performance, and getting back to feeling like yourself. The landing page educates about men's health optimization and offers an assessment — not a prescription. The quiz funnel qualifies: age, symptoms, location, budget expectations. By the time a man books a consultation, he knows exactly what your clinic does, and your ad account never said a restricted word.
Does symptom-led creative convert worse than 'TRT $149/month' would? Per click, sometimes. Per surviving quarter, it wins by default — because the aggressive version's account is dead by week six, along with its pixel data and optimization history.
The layer no platform can switch off
Even perfectly compliant accounts carry platform risk — a policy update, an automated false positive, a category-wide enforcement sweep. Which is why the clinics with durable growth treat paid ads as the accelerant, not the foundation. The foundation is owned and earned visibility: local SEO rankings for 'TRT clinic near me' and 'low testosterone treatment [city],' a Google Business Profile with a deep review moat, treatment pages that answer the questions men research at midnight — and increasingly, AI-search visibility: being the clinic that ChatGPT and Perplexity name when someone asks where to get testosterone levels checked.
Search traffic doesn't get rejected by an algorithm. Reviews don't get banned. And a patient who finds you by asking an AI assistant costs you nothing per click. Paid campaigns then compound on top of that base — and if a platform ever does swing the hammer, your patient flow slows rather than stops.
The practical playbook
- Audit your ad account history and identify exactly which policies past rejections cited.
- Rebuild creative around symptoms and outcomes; scrub restricted terms from ads AND landing pages.
- Add a quiz funnel so pre-qualification happens after the click, where policy doesn't reach.
- Invest in local SEO and AI-search visibility in parallel — your platform-independent base.
- Respond to every inquiry within 60 seconds; restricted-category leads are expensive, so none can leak.
TRT patients are worth $3,000–$8,000 a year in recurring revenue, and demand keeps climbing. The clinics that win won't be the ones that found a loophole — they'll be the ones that built acquisition the platforms can't take away.
Go Deeper
Ready to put this into practice?
Book a free 30-minute strategy call. We'll audit your current patient flow and show you exactly what a full AI acquisition system would generate for your clinic.
Book a Free Strategy Call